Skip to Main Content

Paper Details

EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma.
Journal of Controlled Release
20
2018
ADC, BRAF, Cutaneous melanoma, EV20, HER-3, MMAF, advanced cutaneous melanoma, anti-HER-3 internalizing antibody EV20, auristatin, auristatin MMAF, cancers, cutaneous melanoma, human, human melanoma cell lines, melanoma, melanoma metastases, monomethyl auristatin F, tumor, tumors, vemurafenib
Author NameAffiliation
Manuela IezziUniversity of Chieti-Pescara
  • 1 - 1

Datasets

Release 1.2